Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Immunotoxicity

Currently viewing:

Administrative data

Endpoint:
immunotoxicity: acute dermal
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Scientific method followed conventional research techniques, though no guideline was cited. Good documentation.

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1993

Materials and methods

Principles of method if other than guideline:
Lymphocyte proliferation test method
GLP compliance:
not specified
Limit test:
no

Test material

Constituent 1
Details on test material:
- Purity: Not reported

Test animals

Species:
other: human
Sex:
not specified

Administration / exposure

Route of administration:
dermal
Vehicle:
petrolatum
Duration of treatment / exposure:
72 hours
Frequency of treatment:
single exposure
Doses / concentrations
Remarks:
Doses / Concentrations:
1% (patch test), 0.25 to 10 µg/mL (Lymphoproliferative Assays) and 1 µg/mL (Generation of Antigen-Specific T Cell Lines)
Basis:

No. of animals per sex per dose:
16 Patients
Control animals:
yes

Results and discussion

Effect levels

Dose descriptor:
other: immunotoxicity
Basis for effect level:
other: The test substance is the allergenic, but not the immunogenic agent, in test substance contact sensitivity.  N, N'-bis(4-aminophenyl)-2,5-diamine-1,4-quinone-diimine may be the immunogenic haptan.
Remarks on result:
not measured/tested
Remarks:
Effect level not specified (migrated information)

Any other information on results incl. tables

The test substance is the allergenic, but not the immunogenic agent, in test substance contact sensitivity.  N, N'-bis(4-aminophenyl)-2,5-diamine-1,4-quinone-diimine may be the immunogenic haptan. Optimal stimulation was observed at a concentration of 2 µg/mL. Lymphocyte stimulation was high for 2 patients within the test group. The results of the PBMC PPD-Allergic test show that from the 3 haptens related to the phenylendiamines that were tested in this study, BB is the best indicator of test substance sensitivity in vitro.

 

Hapten-specific T cell lines were generated from PBMC of test substance-allergic patients in the presence of the test substance and BB. Although the test substance-specific T cell line exhibited some proliferative response to the test substance (10E3 at 1 µg/mL), the higher proliferative rate obtained using BB indicated that this cell line was more specific to BB than to the test substance. On the other hand, the BB-specific T cell line did not respond at all to the test substance but strongly proliferated to BB. These data suggest that, in these experiments, the 'test substance-specific' T cells are in fact reactive to BB.

Applicant's summary and conclusion

Conclusions:
The test substance is the allergenic, but not the immunogenic agent.

Executive summary:

A lymphoproliferative assay was performed on human volunteers. The test substance was applied to the upper back for 72 hours. The proliferative response was response was assessed. The test substance is the allergenic, but not the immunogenic agent, in test substance contact sensitivity.  N, N'-bis(4-aminophenyl)-2,5-diamine-1,4-quinone-diimine may be the immunogenic haptan. Optimal stimulation was observed at a concentration of 2 µg/mL. Lymphocyte stimulation was high for 2 patients within the test group. The results of the PBMC PPD-Allergic test show that from the 3 haptens related to the phenylendiamines that were tested in this study, BB is the best indicator of test substance sensitivity in vitro.

 

Hapten-specific T cell lines were generated from PBMC of test substance-allergic patients in the presence of the test substance and BB. Although the test substance-specific T cell line exhibited some proliferative response to the test substance (10E3 at 1 µg/mL), the higher proliferative rate obtained using BB indicated that this cell line was more specific to BB than to the test substance. On the other hand, the BB-specific T cell line did not respond at all to the test substance but strongly proliferated to BB. These data suggest that, in these experiments, the 'test substance-specific' T cells are in fact reactive to BB.